Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Profound Medical stock

Own Profound Medical stock in just a few minutes.

Fact checked

Profound Medical Corp is a medical devices business based in the US. Profound Medical shares (PROF) are listed on the NASDAQ and all prices are listed in US Dollars. Profound Medical employs 75 staff and has a market cap (total outstanding shares value) of USD$462.3 million.

How to buy shares in Profound Medical

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Profound Medical. Find the stock by name or ticker symbol: PROF. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Profound Medical reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Profound Medical, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Profound Medical. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Profound Medical share price

Use our graph to track the performance of PROF stocks over time.

Profound Medical shares at a glance

Information last updated 2021-02-23.
52-week rangeUSD$6.53 - USD$28.97
50-day moving average USD$25.6503
200-day moving average USD$19.421
Wall St. target priceN/A
PE ratio 73.6763
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-1.82

Buy Profound Medical shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Gold/Commodities
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
Stocks, Bonds, Options
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Stocks, Options, Cryptocurrency
Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg
Futures: $2.50/contract to open, $0 to close
Get 100 shares of stock (worth $1 to $6 a share)
Open and fund a new cash or margin account with $2,000+
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
$0 for US stocks
Stocks, Options, ETFs
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Profound Medical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Profound Medical under- or over-valued?

Valuing Profound Medical stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Profound Medical's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Profound Medical's P/E ratio

Profound Medical's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 74x. In other words, Profound Medical shares trade at around 74x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Profound Medical financials

Gross profit TTM USD$3.2 million
Return on assets TTM -17.35%
Return on equity TTM -32.8%
Profit margin -276.82%
Book value N/A
Market capitalisation USD$462.3 million

TTM: trailing 12 months

Shorting Profound Medical shares

There are currently 336,420 Profound Medical shares held short by investors – that's known as Profound Medical's "short interest". This figure is 0.8% down from 339,092 last month.

There are a few different ways that this level of interest in shorting Profound Medical shares can be evaluated.

Profound Medical's "short interest ratio" (SIR)

Profound Medical's "short interest ratio" (SIR) is the quantity of Profound Medical shares currently shorted divided by the average quantity of Profound Medical shares traded daily (recently around 87381.818181818). Profound Medical's SIR currently stands at 3.85. In other words for every 100,000 Profound Medical shares traded daily on the market, roughly 3850 shares are currently held short.

However Profound Medical's short interest can also be evaluated against the total number of Profound Medical shares, or, against the total number of tradable Profound Medical shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Profound Medical's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Profound Medical shares in existence, roughly 20 shares are currently held short) or 0% of the tradable shares (for every 100,000 tradable Profound Medical shares, roughly 0 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Profound Medical.

Find out more about how you can short Profound Medical stock.

Profound Medical share dividends

We're not expecting Profound Medical to pay a dividend over the next 12 months.

Profound Medical share price volatility

Over the last 12 months, Profound Medical's shares have ranged in value from as little as $6.53 up to $28.97. A popular way to gauge a stock's volatility is its "beta".

PROF.US volatility(beta: 1.74)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Profound Medical's is 1.7409. This would suggest that Profound Medical's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Profound Medical overview

Profound Medical Corp. operates as a medical technology company develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, and Finland. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities. The company also offers Sonalleve, a therapeutic platform for the treatment of uterine fibroids and palliative pain treatment of bone metastases, as well as non-invasive treatment of uterine fibroids. Profound Medical Corp. has a co-development agreement with GE Healthcare to expand provider access to TULSA-PRO. Profound Medical Corp. is headquartered in Mississauga, Canada.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site